Live News Categoriesmarket

IDYA.US (IDYA.US) News

Follow IDYA.US (IDYA.US) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol IDYA.US Asset market Sector Markets 90 days 1 Updated Jul 27, 2026, 10:00 AM UTC Open live news feed

L IDYA - IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansio IDYA - IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers EQUITY | Jul 27, 2026, 10:00 AM UTC